<PAGE>
Washington, D.C. 20549
FORM 12b-25
Notification of Late Filing
033-1402 NY
---------------
SEC FILE NUMBER
87-0446395
---------------
---------------
CUSIP NUMBER
64124R 10 7
-----------
(Check One)
[ ] Form 10-KSB [ ] Form 11-K [ ] Form 20-F [X] Form 10-QSB [ ] Form N-SAR
For Period Ended: March 31, 1998
Nothing in this Form shall be construed to imply that the Commission has
verified any information herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:_________________________________
PART I - REGISTRANT INFORMATION
FULL NAME OF REGISTRANT NEUROCORP, LTD.
(Former Name, if Applicable)
Address of Principal Executive Office 150 WHITE PLAINS ROAD
(Street and Number)
City, State and Zip Code TARRYTOWN, NEW YORK 10591
PART II - RULES 12B-25 (B) AND (C)
If the subject report could not be filed without reasonable effort or expense
and the Registrant seeks relief pursuant to Rule 12(b-25(b), the following
should be completed. (Check box if appropriate)
[ X ] (a) The reasons described in reasonable detail in Part II
of this form could not be eliminated without unreasonable
effort or expense;
[ X ] (b) The subject annual report on Form 10-KSB will be filed
on or before the fifteenth calendar day following the
prescribed due date.
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
<PAGE>
PART III - NARRATIVE
State below in reasonable detail the reason why the Form 10-KSB could not be
filed within the prescribed time period.
Registrant was unable to complete a thorough review of drafts
of the report because of business and financial pressures.
The inability to file timely could not be eliminated by the
Registrant without unreasonable effort and expense in that
until such change has been completed, it cannot finalize its
financial statements.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
JOSEPH DIO GUARDI (914) 966 - 0212
----------------- ------------------
(Name) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s).
[ X ] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statement to be included in the subject
report or portion thereof? If so: attach an explanation of the
anticipated change, both narratively and quantitatively, and, if
appropriate, state the reasons why a reasonable estimate of the results
cannot be made.
[ X ] Yes [ ] No
Preliminary indications are that the net loss for the quarter ended
March 31, 1998 will be approximately $ 800,000, as compared to a net
loss of $ 269,078 for the quarter ended March 31, 1997.
<PAGE>
NEUROCORP, LTD.
--------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Dated: May 18, 1998 By: /s/ JOSEPH DIO GUARDI
---------------------
JOSEPH DIO GUARDI
CFO
